ATE: Investor

Where biotech breakthroughs meet investment

Join Europe’s leading CGT investment community for exclusive access to the startups, scaleups, and scientists redefining advanced therapies. At Advanced Therapies Europe 2025, investors gain curated visibility, strategic insight, and unmatched deal-making potential — all in one place.

Meet pre-vetted biotech founders through 1:1 partnering
Join the Investor Summit for peer-to-peer networking and market insight
Scout pre-Series B companies pitching live at the Innovation Exchange
Stay ahead with data-driven discussions on trends, timelines, and ROI
Participate as a judge, moderator, or thought leader

Secure Your Free Investor Pass

Meet the Investor Summit speakers

Aaron Edwards

Co-founder & CEO

Aaron Edwards is the Co-founder & CEO of KiraGen Therapeutics, a biotech company engineering multiplex-edited cell therapies to ov ...
Aleck Jones

Co-founder

Aleck Jones, PhD, is Co-Founder of Kindling Bio, a company dedicated to developing breakthrough therapies for children affected by ...
Alessandra Magnani

Head of the Advanced Therapies and Immunotherapy Platform
Alexander Natz

Secretary General

Alexander Natz is the Secretary General of the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) in Brussels and adv ...
Alexander Seyf

CEO & Cofounder

A seasoned entrepreneur, Business Leader and Management Consultant with strong business acumen and strategic thinking, combined wi ...
Andrea Salmen

COO

Andrea is a highly experienced professional in the biopharmaceutical industry. She has a background in process development and man ...
Andrea Traube

CEO

Dr. Andrea Traube is CEO of KyooBe Tech GmbH, a subsidiary of the Bausch + Ströbel Group, that develops and offers innovative plat ...
Andrew Frazer

Associate Director, Scientific Solutions

Since graduating with a PhD in biochemistry from Queen’s University Belfast, Andrew has attained over 10 years’ experience in the ...
Aneta Tyszkiewicz

Director Digital and Data

Aneta is Director Data and Digital at European Federation of Pharmaceutical Industries and Associations (EFPIA), representing the ...
Angel Lucio

CEO

Ángel Lucio is CEO of Tetraneuron, a Spanish biotech company developing gene therapies to modify and potentially reverse Alzheimer ...
Angela Borghouts de Ruijter

Associate Director Market Access – Cell Therapy

Angela is a pharmacist with an additional master's degree in health economics. For the past six years, Angela has been focusing on ...
Angela Vollstedt

Director Global Cell & Gene Therapies Portfolio
Anna Malinowska

Lead Regulatory Strategist - Biologics Mnufacturing

Anna Malinowska has over 15+ years of expertise in the pharmaceutical industry gained at GSK in Poland and Sandoz in Germany. Sin ...
Anne Douar

Principal & Founder

Anne is a seasoned life sciences executive with over 25 years of experience in gene therapy and rare diseases. Her career has span ...
Anthony Davies

Founder & CEO

Anthony founded Dark Horse Consulting in 2014, bringing his decades of leadership experience in product, process, and manufacturin ...
Antonio Herce

Director

Antonio joined Inveready in 2019. As Investment Director, he leads deal sourcing, due diligence, and portfolio management. He curr ...
Armin Nowack

Senior Vice President Business Development

Armin Nowack is SVP Business Development of Swissfinity Group, a European investment company in the advanced biotech sector. Arm ...
Arnaud Deladeriere

President & Principal Consultant
Artemy Shumskiy

Senior Associate

Artemy Shumskiy is a Senior Associate at LongeVC, where he leverages his scientific expertise in molecular, computational, and agi ...
Arthur Sagoskin

Chief Scientific Development Officer

Dr. Sagoskin is a Reproductive Endocrinologist with extensive expertise in developing the current IVF practice in the US. Prior to ...

Key themes and sessions to discover

Access curated discussions on market trends, valuation shifts, and risk frameworks and enable sharper decision-making and deal selection.
See pre-vetted companies present their value proposition in real-time and efficiently scan pipeline potential and find hidden gems.
Learn which CGT business models are surviving current market pressures to better identify who will deliver ROI.
Pre-schedule meetings with founders and fellow VCs to accelerate diligence and fosters co-investment opportunities.

Must attend sessions

Panel: Bridging the funding gap – How to get from pre-clinical to clinical without stalling out
Panel: The reality of raising funds for CGT startups
Innovation Exchange (startups pitch to investors)
Panel: The state of the CGT industry & turning the future into action
Roundtables: Investor expectations: what do you need for each funding stage?

Investment Summit Agenda

Library couldn't be loaded. It might not be active.

Discover Advanced Therapies Week as an investor

Explore how Advanced Therapies Week empowers biotechs to accelerate their commercialization journey. From engaging with investors at our exclusive Investor Pre-Day to building valuable partnerships with industry leaders, every moment is designed to drive your success. Dive into the agenda, connect with peers, and meet solution providers ready to support your growth.

Content Packed Agenda

Start with macro and micro trends shaping CGT investment — from capital flows to platform-based valuations.

Founders in Focus

Biotech CEOs share real-world experiences in securing funding, navigating milestones, and scaling in complex markets.

Investor Sessions

Get behind-the-scenes access to the thinking of investors from firms like BroadOak Capital Partners, 4BIO Capital, and Saisei Ventures.

Strategic Networking

1:1 meetings and informal conversations with decision-makers continue throughout ATE — the summit is your introduction.

Who might you find on the show floor?

Sample Attendee List Current Exhibitor List

500+

Attendees

40+

Countries

150+

Speakers

170+

Therapeutic Developers

“I get SO MUCH information at this show that sets me up for the year. It’s what I love about it. To me, ATW is the start of the year.”

Principal, WMC
“The Super Bowl of Advanced Cell Therapy conferences.”

Patient & Author, Killing Cancer with TILs
"Everyone that has a word to say, or a finger on the lifecycle of a cell therapy product should come here…”

President & CEO, Co-founder, NKILT Therapeutics Inc.
“Advanced Therapies Week has been the epicenter of the cell & gene therapy revolution. This is a dynamic and must-attend forum where breakthrough technologies and impactful partnerships come to life to transform drug development.”

Bullpen